RxDoctor Payments Data

Jacob Eide, MD

Otolaryngology · Detroit, MINPI 1386008084

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 90.6% of the total across 40 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 10 manufacturers reported payments, led by Acclarent, Inc at 42.3% of the total. Reporting peaked in 2023 at $1,434 and has fallen 66.1% since, to $487 in 2025.

$4,324in general payments, 2019–2025

Across 40 payments — averaging $108.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Acclarent, Inc$2K
  • Integra Lifesciences Corporation$874
  • Aerin Medical Inc.$824
  • Intersect ENT, Inc.$424
  • Stryker$156
  • Neurent Medical Limited$127
  • plus $88 from 4 others
$2,000in research payments, 2019–2025

Across 1 payment — averaging $2000.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Aerin Medical Inc.$2K

What the payments were for

  • Consulting fees$4069%
  • Food & beverage$3,91991%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,324 in reported general payments places this provider in the 75th percentile of 257 otolaryngology providers in Michigan.

See all otolaryngology providers in Michigan

Medicare billing

Part B allowed, 2024
$83,193
Medicare patients
129
Services billed
404

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Fluticasone Propionate33$362
Oxycodone Hcl11$17

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Detroit

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →